Activated factor VIII-mimetic prophylaxis associated with reduced bleeding in hemophilia A
1. In adolescents and adults with hemophilia A, subcutaneous Mim8 prophylaxis reduced treated bleeding events versus on-demand therapy and versus ...
Tag: hemophilia with inhibitors
Concizumab reduces bleeding episodes in hemophilia patients with inhibitors
1. In this phase three open-label randomized trial, concizumab prophylaxis reduced the annualized bleeding rate in patients with hemophilia with ...
